Serum Gamma-glutamyltransferase Levels and the Risks of Impaired Fasting Glucose in Healthy Men: A 2-year Follow-up

Journal of Preventive Medicine and Public Health

Volumn 39, Issue 4, 2006, Pages 353-358

  Shin, Joo Youn ^a   Lim, Jong Han ^b   Koh, Dai Ha ^c   Kwon, Keun Sang ^c   Kim, Yong Kyu ^d   Kim, Hwan Chul ^b   Lee, Yeui Cheol ^b   Lee, Ju Hyoung ^c   Nam, Moon Suk ^b   Hong, Sung Bin ^b   Park, Shin Goo ^a  

^a Industrial Safety and Health Bureau   (South Korea)

^b Inha University Hospital   (South Korea)

^c Chonbuk National University   (South Korea)

^d The Catholic University of Korea   (South Korea)

Author keywords

Diabetes; Gamma glutamyltransferase; Impaired fasting glucose; Prediabetes

Indexed keywords

BIOLOGICAL MARKER; GAMMA GLUTAMYLTRANSFERASE;

ARTICLE; BLOOD; DIABETES MELLITUS; DIET RESTRICTION; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; MALE; PROSPECTIVE STUDY; RISK;

BIOLOGICAL MARKERS; BLOOD GLUCOSE; DIABETES MELLITUS; FASTING; FOLLOW-UP STUDIES; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; MALE; PROSPECTIVE STUDIES; RISK;

EID: 33748470562     PISSN: 19758375     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Whmeld JB. Gamma glutamyl transferase. Crit Rev Clin Lab Sci;3S(4): 263-355.
2. Yi KN, Kwon OH. Clinical Pathology File, 3rd Ed. Seoul, Eui-Hak Publishing & Printing Co; 2000. p. 367-370 (Korean).
3. Wannamethee G, Ebrahim S, Shaper AG. Gamma-glutamyllransferase: determinants and association with from ischemic heart disease and all causes. Am J Epidemiol 1995; 142(7): 699-708.
4. Pintus F, Mascia P. Distribution and population determinants of gamma-glutamyllransferase in a random sample of Sardinian inhabitants. ATS-SARDEGNÁResearch Group. EurJEpidemol 1996; 12(1): 71-76.
5. Whilehead TP, Robinson D, Allaway SL The effects of cigarette smoking and alcohol consumption on serum liver enzyme activities: a dose-related study in men. Ann Clin Biochem 1996; 33(6): 530-535.
6. Kim KY, Kam S, Lee JH, Ha YA, Lee KE. A cross-sectional study on gamma-GTP and its related factors in male workers. Korean J Prev Med 2002; 35(2): 169-174 (Korean).
7. Kim SH, Lee JN, Hong YC. Effect of commuting time on male workerś serum gamma-glutamyltransferase level. Korea J Occup Environ Med 2002; 14(4): 418425 (Korean).
8. Yamada Y, Noborisaka Y, Suzuki H, Ishizaki M, Yamada S. Alcohol consumption, serum gamma-glutamyltransferase levels, and coronary risk factors in a middle-aged occupational population. J Occup Health 2003; 45(5): 293-299.
9. Stranges S, Dom JM, Muti P, Freudenheim JL, Farinaro E, Russell M, NochajsM TH, Trevisan M. Body fat distribution, relative weight, and liver enzyme levels: a population-based study. Hepatobgy 2004; 39(3): 754-763.
10. Shin JY, Kim YK, Park SG, Lee JN, Kim HC, Lee JH, Hong YC. The clinical importance of an increase in serum gamma-glutamyltransferase concentration. Korea J Occup Environ Med 2005; 17(1): 1-9 (Korean).
11. Lim JS, Yang JH, Chun BY, Kam S, Jacobs DR Jr, Lee DH. Is serum gammaglutamyltrans-ferase inversely associated with serum antioxidante as a marker of oxidative stress? Free Radic Biol Med 2004;31(1):1018-1023.
12. Bhatia S, Shukla R, Venkata Madhu S, Kaur Gambhir J, Madhava Prabhu K. Antioxidant status, liprid peroxidation and nitric oxide end products of type 2 diabetes mellitus with nephropathy. Clin Biochem 2003; 36(7): 557-562.
13. Atli T, Keven K, Avci A, Kutlay S, Turkcapar N, Varli M, Aras S, Ertug E, Canbolat 0. Oxidative stress and antioxidant status in elderly diabetes mellitus and glucose intolerance patients. Arch Gerontol Geriatr 2004; 39(3): 269-275.
14. Delles C, Schneider MP, Oehmer S, Fleischmann I, Fleischmann EF, Schmieder RE. Increased response of renal perfusion to the antioxidant vitamin C in type 2 diabetes. Nephrol Dial Transplant 2004; 19(10): 2513-2518.
15. Lee DH, Ha MH, Kim JH, Christiani DC, Gross MD, Steffes M, Blomhoff R, Jacobs Dr Jr. Gamma-glutamyltransferase and diabetes-a 4 year follow-up study. Diabetologia 2003a; 46(3): 359-364.
16. Lee DH, Jacobs DR Jr, Gross M, Kiefe CI, Roseman J, Lewis CE, Steffes M. Gamma-glutamyltransferase is a predictor of incident diabetes and hypertension: the Coronary Artery Risk Development in Young Adults(CARDIA) study. Clin Chem 2003b; 49(8): 1358-1366.
17. Nakanishi N, Nishina K, Li W, Sato M, Suzuki K, Tatara K. Serum gamma-glutamyllransferase and development of impaired fasting glucose or type 2 diabetes in middle-aged Japanese men.J Intern Med 2003; 254(3): 287-295
18. Nakanishi N, Suzuki K, Tatara K. Serum gamma-glutamyltransferase and risk of metabolic syndrome and type 2 diabetes in middle-aged Japanese men. Diabetes C care 2004; 27(6): 1427-1432.
19. Arndt V, Brenner H, Rothenbacher D, Zschenderlein B, Fraisse E. Elevated liver enzyme activity in construction workers: prevalence and impact on early retirement and all cause mortality. Int Arch Occup Environ Health 1998; 71(6): 405-412.
20. van der Vaart H, Postma DS, Timens W, ten Hacken NH. Acute effects of cigarette smoke on inflammation and oxidative stress: a review. Thorax 2004; 59(8): 713-721.
21. Mofler P, Wallin H, Knudsen LE. Oxidative stress associated with exercise, psychological stress and life-style factors. Chem Biol Interact 1996; 102(1): 17-36.
22. Lesgards JF, Durand P, Lassarre M, Stacker P, Lesgards G, Lanteaume A, Prost M, Lehucher-Mchel MP. Assessment of lifestyle effects on the overall antioxidant capacity of healthy subjects. Environ Health Perspect 2002; 110(5): 479-486.
23. Park E, Kang MH. Smoking and high plasma triglyceride levels as risk factors for oxidative DNA damage in the korean population. An Nutr Metab 2004; 48(1): 36-42
24. Scott JA, King GL. Oxidative stress and antioxidant treatment in diabetes. Ann N Y Acad Sci 2004; 1031:204-213.
25. World Health Organization(WHO). Diabetes Programme. Available from URL http://www. who.int/diabetes/en/.
26. The Korea Geriatrics Society. Textbook of Geriatric Medicine, 2nd Ed. Seoul, Medical Publishing Co; 2005. p. 774-784 (Korean).
27. Korea National Statistical Office. Statistics information system. Mortality statMcs(1983-2004). Available from: http://wwwsearch.nso.go.kr.
28. Alexander CM, Landsman PB, Teutsch SM. Diabetes mellitus, impaired fasting glucose, atherosclerotic risk factors, and prevalence of coronary heart disease. Am J Cardiol 2000; 86(9): 897-902.
29. Chen KT, Chen CJ, Gregg EW, Imperatore G, Narayan KM. Impaired fasting glucose and risk of diabetes in Taiwan: follow-up over 3 years. Diabetes Res Clin Pract 2003; 60(3): 177-182.
30. Qiao Q, Jousflahti P, Eriksson J, Tuomilehto J. Predictive properties of impaired glucose tolerance for cardiovascular risk are not explained by the development of overt diabetes during follow-up. Diabetes Care 2003; 26(10): 2910-291.
31. Heldgaard PE, Olivarius Nde F, Hindsberger C, Henriksen JE. Impaired fasting glycemia resembles impaired glucose tolerance with regard to cardiovascular risk factors: population-based, cross-sectional study of risk factors for cardiovascular disease. Diabet Med 2004; 21(4): 303-304.
32. Soderberg S, Zimmet P, Tuomilehto J, de Courten M, Dowse GK, Chitson P, Stenlund H, Gareeboo H, Alberti KG, Shaw J. High incident of type 2 diabetes and increasing conversion rates from impaired fasting glucose and impaired glucose tolerance to diabetes in Mauritius. J Intern Med 2004; 256(1): 37-47.
33. Wang JJ, Yuan SY, Zhu LX, Fu HJ, Li HB, Hu G, Tuomilehto J. Effects of impaired fasting glucose and impaired glucose tolerance on predicting incident type 2 diabetes in a Chinese population with high post-prandial glucose. Diabetes Res Clin Pract 2004; 66(2): 183-191.